Methuselah
Their stated focus (public profile)
Methuselah Fund invests in longevity and anti-aging biotechnology companies with the mission of making 90 the new 50 by 2030. The fund targets technologies that extend healthy human lifespan across areas such as organ regeneration, senolytics, epigenetic reprogramming, cancer therapy, and regenerative medicine. Success is measured by both financial returns and mission advancement, with mission as the priority. The fund stems from The Methuselah Foundation, leveraging its 16+ years of relationships in the longevity field.
Sectors: Longevity, Life sciences, Healthtech
On file: 5 partners on record · 8 companies on record
Website: methuselahfund.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.